BioSpace News Archive

Business

Dyne Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights

Dyne Therapeutics, Inc. today reported financial results for the second quarter 2021 and business highlights.

August 5, 2021
·
7 min read
Business

XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events

XOMA Corporation reported its second quarter 2021 financial results and provided a recent operations update.

August 5, 2021
·
10 min read
Business

In Memoriam – Friend, Scientific Innovator, Advisor and Board Chair Dr. Tadataka Yamada Has Passed Away

Prometheus Biosciences, Inc., with great sorrow announced that its Chairman of the Board, Tadataka Yamada, M.D., KBE, passed away unexpectedly on August 4, 2021.

August 5, 2021
·
2 min read
Business

Ironwood Pharmaceuticals Reports Strong Second-Quarter 2021 Results, Raises Full-Year Guidance

Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, reported financial results for second quarter 2021 and raised full year 2021 financial guidance.

August 5, 2021
·
32 min read
Business

Aldeyra Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Corporate Highlights

Aldeyra Therapeutics, Inc., a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, reported financial results for the quarter ended June 30, 2021 and recent corporate highlights.

August 5, 2021
·
12 min read
Business

Verona Pharma Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the three months ended June 30, 2021, and provides a corporate update.

August 5, 2021
·
15 min read
Business

Zealand Pharma Hosts Conference Call on August 12 at 4 pm CET (10am ET) to Present Second Quarter Results for 2021

Zealand Pharma A/S a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announced that it will host a conference call on August 12, 2021 at 4 pm CET following the announcement of results for the second quarter of 2021.

August 5, 2021
·
3 min read
Biotech Beach

Praxis Bioresearch Awarded $2.9 Million Fast-Track SBIR Grant for Development of Novel Therapy for Apathy in Alzheimer’s Disease

Praxis is proud to announce to be the recipient of a Fast-Track SBIR award to develop treatment for apathy in Alzheimer’s Disease.

August 5, 2021
·
5 min read
Business

Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update

Amarin Corporation plc, announced financial results for the second quarter and six months ended June 30, 2021 and provided an update on company operations.

August 5, 2021
·
33 min read
Drug Development

Phase 3 Trial of Libtayo® (cemiplimab-rwlc) Combined with Chemotherapy Stopped Early Due to Significant Improvement in Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer

Regeneron Pharmaceuticals, Inc. and Sanofi announced the Phase 3 trial of PD-1 inhibitor Libtayo in combination with platinum-doublet chemotherapy was stopped early after meeting its overall survival primary endpoint in patients with advanced non-small cell lung cancer.

August 5, 2021
·
21 min read